Ipamorelin (10mg)
Growth Hormone Research
Research Use Only — Not for Human or Veterinarian Administration

Ipamorelin (10mg)

Ipamorelin is a selective growth-hormone releasing peptide studied for GHS-R1a activity with minimal impact on cortisol and prolactin in research models.

Ipamorelin (10mg)$57.00
View only
View Certificate of AnalysisThird-party HPLC lab report · opens PDF

Mechanism of Action

CJC-1295 activates GHRH receptors; Ipamorelin selectively stimulates GHS-R1a with minimal cortisol/prolactin elevation in research models. Combined protocols explore synergistic GH pulse amplification.

Research Applications

  • Dual secretagogue GH axis research
  • Comparative single vs. blend protocol studies
  • GHS-R and GHRH receptor interaction assays

Specifications

sequenceCJC-1295 + Ipamorelin blend
molecular WeightBlend — see component COAs
appearanceWhite lyophilized powder

Reconstitution (Laboratory)

Reconstitute with bacteriostatic water. Confirm component masses via COA.

Storage & Handling

Lyophilized: 2–8 °C. Reconstituted: refrigerate.

Quality Assurance

Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.

Sources & References

  1. 1.Raun K, et al. Ipamorelin, a new growth-hormone-releasing peptide, potently and selectively. J Endocrinol. 1998. · PubMed →
  2. 2.Teichman SL, et al. CJC-1295 pharmacokinetics. J Clin Endocrinol Metab. 2006. · PubMed →